JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on July 2, 2004
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
279/27/28028    most recent
M313939200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, M.
Right arrow Articles by Fitzpatrick, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, M.
Right arrow Articles by Fitzpatrick, F. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print April 27, 2004
J. Biol. Chem, 10.1074/jbc.M313939200
Submitted on December 19, 2003
Revised on April 27, 2004
Accepted on April 27, 2004

Conditional expression of 15-lipoxygenase-1 inhibits the selenoenzyme thioredoxin reductase: Modulation of selenoproteins by lipoxygenase enzymes

Margaret Yu, Philip J. Moos, Pamela Cassidy, Mark Wade, and Frank A. Fitzpatrick

Oncological Sciences, University of Utah, Salt Lake City, Utah 84112-5550

Corresponding Author: frank.fitzpatrick{at}hci.utah.edu

The selenoenzyme thioredoxin reductase regulates redox-sensitive proteins involved in inflammation and carcinogenesis, including ribonucleotide reductase, p53, NFkappa B, and others. Little is known about endogenous cellular factors that modulate thioredoxin reductase activity. Here we report that several metabolites of 15-lipoxygenase-1 inhibit purified thioredoxin reductase in vitro. 15(S)-Hydroperoxy-5, 8, 11-cis -13-trans- eicosatetraenoic acid, a metastable hydroperoxide generated by 15-lipoxygenase-1, and 4-hydroxy-2-nonenal, its non-enzymatic rearrangement product inhibit thioredoxin reductase with IC50 = 13 ± 1.5 mu M and 1 ± 0.2 mu M, respectively. Endogenously generated metabolites of 15-lipoxygenase-1 also inhibit thioredoxin reductase in HEK 293 cells that harbor a 15-LOX-1 gene under the control of an inducible promoter complex. Conditional, highly selective induction of 15-lipoxygenase-1 caused an inhibition of ribonucleotide reductase activity, cell cycle arrest in G1, impairment of anchorage-independent growth, and accumulation of the pro-apoptotic protein BAX. All of these responses are consistent with inhibition of thioredoxin reductase via 15-lipoxygenase-1 overexpression. In contrast, metabolites of 5-lipoxygenase were poor inhibitors of isolated thioredoxin reductase, and the overexpression of 5-lipoxygenase did not inhibit thioredoxin reductase or cause a G1 cell cycle arrest. The influences of 15-lipoxygenase-1 on inflammation, cell growth and survival may be attributable, in part, to inhibition of thioredoxin reductase and several redox-sensitive processes subordinate to thioredoxin reductase.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Cordray, K. Doyle, K. Edes, P. J. Moos, and F. A. Fitzpatrick
Oxidation of 2-Cys-peroxiredoxins by Arachidonic Acid Peroxide Metabolites of Lipoxygenases and Cyclooxygenase-2
J. Biol. Chem., November 9, 2007; 282(45): 32623 - 32629.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. B. Cassidy, K. Edes, C. C. Nelson, K. Parsawar, F.A. Fitzpatrick, and P. J. Moos
Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles
Carcinogenesis, December 1, 2006; 27(12): 2538 - 2549.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Torosyan, A. Dobi, S. Naga, K. Mezhevaya, M. Glasman, C. Norris, G. Jiang, G. Mueller, H. Pollard, and M. Srivastava
Distinct Effects of Annexin A7 and p53 on Arachidonate Lipoxygenation in Prostate Cancer Cells Involve 5-Lipoxygenase Transcription
Cancer Res., October 1, 2006; 66(19): 9609 - 9616.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. M. Lippman and J. J. Lee
Reducing the "Risk" of Chemoprevention: Defining and Targeting High Risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
Cancer Res., March 15, 2006; 66(6): 2893 - 2903.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Shureiqi, Y. Wu, D. Chen, X. L. Yang, B. Guan, J. S. Morris, P. Yang, R. A. Newman, R. Broaddus, S. R. Hamilton, et al.
The Critical Role of 15-Lipoxygenase-1 in Colorectal Epithelial Cell Terminal Differentiation and Tumorigenesis
Cancer Res., December 15, 2005; 65(24): 11486 - 11492.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. R. Hirsch and S. M. Lippman
Advances in the Biology of Lung Cancer Chemoprevention
J. Clin. Oncol., May 10, 2005; 23(14): 3186 - 3197.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. M. Lippman and B. Levin
Cancer Prevention: Strong Science and Real Medicine
J. Clin. Oncol., January 10, 2005; 23(2): 249 - 253.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. J. Duffield-Lillico, I. Shureiqi, and S. M. Lippman
Can Selenium Prevent Colorectal Cancer? A Signpost From Epidemiology
J Natl Cancer Inst, November 17, 2004; 96(22): 1645 - 1647.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.